A comparison of the application of STOPP/START to patients' drug lists with and without clinical information

International Journal of Clinical Pharmacy

Volumn 35, Issue 2, 2013, Pages 230-235

  Ryan, Cristín ^a,b   O'Mahony, Denis ^c   O'Donovan, Dónal Óg ^b   O'Grady, Emer ^b   Weedle, Peter ^b   Kennedy, Julia ^b   Byrne, Stephen ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c University College Cork and INFANT Centre   (Ireland)

Author keywords

Community pharmacists; Ireland; Older patients; Prescribing; Screening tools; STOPP START criteria

Indexed keywords

ANTITHROMBOCYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BISPHOSPHONIC ACID DERIVATIVE; PROTON PUMP INHIBITOR;

AGED; ARTICLE; CONSENSUS; CONTROLLED STUDY; FEMALE; HUMAN; INAPPROPRIATE PRESCRIBING; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICATION THERAPY MANAGEMENT; OUTCOME ASSESSMENT; PHARMACIST; PHARMACY; POTENTIAL PRESCRIBING OMISSION; POTENTIALLY INAPPROPRIATE MEDICINE; PRIORITY JOURNAL; STOPP START CRITERIA; TREATMENT DURATION; CLINICAL PRACTICE; COMPARATIVE STUDY; EUROPE; ORGANIZATION AND MANAGEMENT; STANDARD; STATISTICS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COMMUNITY PHARMACY SERVICES; EUROPE; FEMALE; HUMANS; INAPPROPRIATE PRESCRIBING; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PHARMACISTS; PHYSICIAN'S PRACTICE PATTERNS;

EID: 84884468932     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-012-9733-0     Document Type: Article

References (20)

1. Gallagher P, O'Mahony D. Inappropriate prescribing in older people. Rev Clin Gerontol. 2008;12: 65-76.
2. Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57: 6-14.
3. Milton JC, Hill-Smith I, Jackson SHD. Prescribing for older people. BMJ. 2008;336: 606-9.
4. Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46: 72-83.
5. Ryan C, O'Mahony D, Kennedy J, Weedle P, Byrne S. Potential inappropriate prescribing in an Irish elderly population in primary care. Br J Clin Pharmacol. 2009;68: 936-47.
6. Gallagher P, O'Mahony D. STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing. 2008;37: 673-9.
7. Barry PJ, Gallagher P, Ryan C, O'Mahony D. START (screening tool to alert doctors to the right treatment)-an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing. 2007;36: 632-8.
8. O'Sullivan D, O'Mahony D, Parsons C, Hughes C, Patterson S, Byrne S. Inappropriate prescribing in Irish nursing homes residents. EGM. 2011;2:S11-2.
9. Gallagher PF, O'Connor MN, O'Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther. 2011;89: 845-54.
10. Hamilton H, Gallagher P, Ryan C, Byrne S, O'Mahony D. Potentially inappropriate medications defined by STOPP Criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med. 2011;171: 1013-9.
11. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22): 2716-24.
12. National Service Framework for older people. Implementing medicines related aspects of the NSF for older people. London: Department of Health; 2001.
13. Department of Health. The pharmaceutical services (advanced and enhances services) (England), Amendment directions. 2006. http://www.dh.gov.uk/assetRoot/ 04/10/75/97/04107597.pdf. Last accessed 29 July 2012.
14. Ryan C, O'Mahony D, Byrne S. Application of STOPP and START criteria: inter-rater reliability among pharmacists. Ann Pharmacother. 2009;43: 1239-44.
15. Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med. 2003;25: 144-53.
16. Reid F, Murray P, Storrie M. Implementation of a pharmacist-led clinic for hypertensive patients in primary care-a pilot study. Pharm World Sci. 2005;27: 202-7.
17. Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, et al. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ. 2001;323: 1340-3.
18. Lenaghan E, Holland R, Brooks A. Home-based medication review in a high risk elderly population in primary care-the POLYMED randomised controlled trial. Age Ageing. 2007;36: 292-7.
19. Laaksonen R, Duggan C, Bates I. Performance of community pharmacists in providing clinical medication reviews. Ann Pharmacother. 2010;44: 1181-90.
20. Krska J, Avery AJ. Evaluation of a medication review conducted by community pharmacists: a quantitative analysis of documented issues and recommendations. Br J Clin Pharmacol. 2007;65: 386-96.